VLX-1570 | Interleukin Related interleukin-related.com

Product Name :
VLX-1570

Search keywords :
USP14

drugId :
null

Target Vo:
Ubiquitin C-terminal hydrolase L5

Target Vo Short Name :
UCHL5

Moa_Name:
Ubiquitin specific peptidase 14 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Vivolux Ab

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Multiple Myeloma

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Rituximab (anti-CD20) Protocol
Survivin Rabbit mAb Protocol
ATF6 Antibody (YA604): ATF6 Antibody (YA604) is a non-conjugated and Rabbit origined monoclonal antibody about 75 kDa, targeting to ATF6. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts